Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib
収録刊行物
-
- Cancer Letters
-
Cancer Letters 472 81-96, 2020-03
Elsevier BV